Hostname: page-component-7c8c6479df-27gpq Total loading time: 0 Render date: 2024-03-28T00:44:48.772Z Has data issue: false hasContentIssue false

Alzheimer Testing at Silver Years

Published online by Cambridge University Press:  01 July 1998

A. MATHEW THOMAS
Affiliation:
Harvard University
GENE COHEN
Affiliation:
Center on Aging, Health, and the Humanities at the George Washington University
ROBERT M. COOK-DEEGAN
Affiliation:
National Cancer Policy Board, National Academy of Sciences and Institute of Medicine
JOAN O'SULLIVAN
Affiliation:
University of Maryland Law School
STEPHEN G. POST
Affiliation:
Ethical, Legal, and Social Implications Program of the National Human Genome Research Institute and the Center for Biomedical Ethics, School of Medicine, Case Western Reserve University
ALLEN D. ROSES
Affiliation:
Glaxo Wellcome
KENNETH F. SCHAFFNER
Affiliation:
George Washington University, Washington, D.C.
RONALD M. GREEN
Affiliation:
Ethics Institute at Dartmouth College, Hanover, New Hampshire

Abstract

Early last year, the GenEthics Consortium (GEC) of the Washington Metropolitan Area convened at George Washington University to consider a complex case about genetic testing for Alzheimer disease (AD). The GEC consists of scientists, bioethicists, lawyers, genetic counselors, and consumers from a variety of institutions and affiliations. Four of the 8 co-authors of this paper delivered presentations on the case. Supplemented by additional ethical and legal observations, these presentations form the basis for the following discussion.

Type
Research Article
Copyright
© 1998 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)